BEXINIB(Axitinib)
Therapeutic class: Kinase Inhibitors
Indication: Advanced renal cell carcinoma (RCC) after failure of one prior systemic therapy.
1 mg & 5 mg tablets
1 mg:-
A bottle of 14 tablets5 mg:-
A bottle of 14 tablets- 20°C to 25°C (68°F to 77°F), Shelf Life: 2 Years
- As directed by physician
